Home Page

for LDL-Cholesterol Reduction in Primary and Secondary Prevention

Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary Prevention

Date: Friday, February 28, 2018

Registration & Dinner: 6:45 PM - 7:00 PM
Symposium Time: 7:00 PM - 9:00 PM CST

Hyatt Hill Country
Fredericksburg Ballroom A-D
9800 Hyatt Resort Drive
San Antonio, Texas

Registration for this program is now closed.

James Underberg, MD, MS

  Alan Brown, MD
  Peter Jones, MD
  Pamela Morris, MD

Program Overview:
This program will focus on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention. An interpretation of recently presented and published secondary analyses from cardiovascular outcome trials with non-statin agents will provide lipid specialists with a more comprehensive evaluation of the efficacy and safety of non-statin therapy in patients with atherosclerotic cardiovascular disease (ASCVD). Attendees will also receive an expert assessment of non-statin therapy for primary prevention. Four interactive challenging cases for lipid specialists with “real-world” patients will enable faculty members to describe best management strategies.

Educational Objectives: 
Upon completion of this program, attendees should be able to:
  • Explain the data from clinical studies with non-statin therapies for LDL-C lowering in primary and
         secondary prevention patient populations.
  • Describe the roles for PCSK9 inhibitors and ezetimibe based on clinical trial evidence.
  • Identify multiple factors in selecting non-statin therapy for lowering LDL-C.
  • Recognize updated treatment recommendations for non-statin therapies in clinical practice guidelines.
  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

    Free CME Here

    Target Audience:  This activity is designed to meet the needs of lipidologists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

    Physician Credit Designation Statement:
    The National Lipid Association designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in this activity.

    Physician Assistants

    NCCPA accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.


    The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 2 continuing professional education units (CPEUs) for completion of this program/materials. CDR Accredited Provider #NL002.


    Universal Activity Number - J0007192-9999-18-004-L01-P (Application) This Activity has been approved for 2.00 contact hour(s) (.2 CEUs) of the Accreditation Council for Pharmacy Education.


    The maximum number of hours awarded for this CE activity is 2.0 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

    Commercial Support: This activity is supported by an educational donation provided by Amgen.